Every reason to discontinue lithium

Manuel E.Fuentes Salgado, Bruce Sutor, Robert C. Albright, Mark A Frye

Research output: Contribution to journalLetter

2 Citations (Scopus)

Abstract

Lithium as a gold standard therapy for bipolar disorder is well known to have a number of medical comorbidities that impact renal, parathyroid, and thyroid function. Despite these medical comorbidities, there remains a group of lithium-responsive lithium-treated patients who have maintained mood stability for decades. The risk/benefit ratio of end organ toxicity/mood stability must be evaluated in each individual case.

Original languageEnglish (US)
Pages (from-to)1-3
Number of pages3
JournalInternational Journal of Bipolar Disorders
Volume2
Issue number1
DOIs
StatePublished - Jan 1 2014

Fingerprint

Lithium
Comorbidity
Bipolar Disorder
Thyroid Gland
Odds Ratio
Kidney
Therapeutics

Keywords

  • Efficacy
  • Lithium
  • Toxicity

ASJC Scopus subject areas

  • Biological Psychiatry
  • Psychiatry and Mental health

Cite this

Every reason to discontinue lithium. / Salgado, Manuel E.Fuentes; Sutor, Bruce; Albright, Robert C.; Frye, Mark A.

In: International Journal of Bipolar Disorders, Vol. 2, No. 1, 01.01.2014, p. 1-3.

Research output: Contribution to journalLetter

Salgado, Manuel E.Fuentes ; Sutor, Bruce ; Albright, Robert C. ; Frye, Mark A. / Every reason to discontinue lithium. In: International Journal of Bipolar Disorders. 2014 ; Vol. 2, No. 1. pp. 1-3.
@article{9a2a75cbdef64b43a5d931477ea849ab,
title = "Every reason to discontinue lithium",
abstract = "Lithium as a gold standard therapy for bipolar disorder is well known to have a number of medical comorbidities that impact renal, parathyroid, and thyroid function. Despite these medical comorbidities, there remains a group of lithium-responsive lithium-treated patients who have maintained mood stability for decades. The risk/benefit ratio of end organ toxicity/mood stability must be evaluated in each individual case.",
keywords = "Efficacy, Lithium, Toxicity",
author = "Salgado, {Manuel E.Fuentes} and Bruce Sutor and Albright, {Robert C.} and Frye, {Mark A}",
year = "2014",
month = "1",
day = "1",
doi = "10.1186/s40345-014-0012-y",
language = "English (US)",
volume = "2",
pages = "1--3",
journal = "International Journal of Bipolar Disorders",
issn = "2194-7511",
publisher = "Springer Open",
number = "1",

}

TY - JOUR

T1 - Every reason to discontinue lithium

AU - Salgado, Manuel E.Fuentes

AU - Sutor, Bruce

AU - Albright, Robert C.

AU - Frye, Mark A

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Lithium as a gold standard therapy for bipolar disorder is well known to have a number of medical comorbidities that impact renal, parathyroid, and thyroid function. Despite these medical comorbidities, there remains a group of lithium-responsive lithium-treated patients who have maintained mood stability for decades. The risk/benefit ratio of end organ toxicity/mood stability must be evaluated in each individual case.

AB - Lithium as a gold standard therapy for bipolar disorder is well known to have a number of medical comorbidities that impact renal, parathyroid, and thyroid function. Despite these medical comorbidities, there remains a group of lithium-responsive lithium-treated patients who have maintained mood stability for decades. The risk/benefit ratio of end organ toxicity/mood stability must be evaluated in each individual case.

KW - Efficacy

KW - Lithium

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=85012288028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012288028&partnerID=8YFLogxK

U2 - 10.1186/s40345-014-0012-y

DO - 10.1186/s40345-014-0012-y

M3 - Letter

AN - SCOPUS:85012288028

VL - 2

SP - 1

EP - 3

JO - International Journal of Bipolar Disorders

JF - International Journal of Bipolar Disorders

SN - 2194-7511

IS - 1

ER -